Inventor · disambiguated record
Katrin Rimkus
Also filed as: RIMKUS KATRIN
4 granted patents·18 pending applications·4 citations·filing 2008–2015
61Inventor score
Top patents by PatentIndex Score
22 records- 0173US8586091B2Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-quinazolinamineRIMKUS KATRIN·Filed 2009·Granted Nov 19, 2013·3 cites·10 claims
- 0269US9238007B2Method for the production of a medicament containing tadalafilALLES RAINER·Filed 2008·Granted Jan 19, 2016·1 cites·8 claims
- 0359US2011300214A1Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamidRIMKUS KATRIN·Filed 2009·Application pending·0 cites
- 0457US2011189279A1Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamidRATIOPHARM GMBH·Filed 2009·Application pending·0 cites
- 0555US2011189243A1Pharmaceutical formulation for lowering pulmonary blood pressureRATIOPHARM GMBH·Filed 2009·Application pending·0 cites
- 0653US2013281457A1Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamidRATIOPHARM GMBH·Filed 2013·Application pending·0 cites
- 0751US2012015965A1Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy] phenyl]-6-[5[[[2-(methylsulfonyl) ethyl]amino]methyl]-2-furyl]-4- quinazolinamineRIMKUS KATRIN·Filed 2009·Application pending·0 cites
- 0849US2011313050A1Solid composition containing the ingredient rasagilineRIMKUS KATRIN·Filed 2009·Application pending·0 cites
- 0948US2013345310A1Solid composition containing the ingredient rasagilineRIMKUS KATRIN·Filed 2013·Application pending·0 cites
- 1047US2016101103A1Method for the production of a medicament containing tadalafilRATIOPHARM GMBH·Filed 2015·Application pending·0 cites
- 1141US2012046315A1Intermediate and oral administrative formats containing lenalidomideRIMKUS KATRIN·Filed 2009·Application pending·0 cites
- 1240US2016081971A1Method for producing dosage form comprising odanacatibRATIOPHARM GMBH·Filed 2014·Application pending·0 cites
- 1339US2015246043A1Oral dosage forms for modified release comprising ruxolitinibRATIOPHARM GMBH·Filed 2013·Application pending·0 cites
- 1435US8703203B2Oral dosage form of deferasiroxPAETZ JANA·Filed 2011·Granted Apr 22, 2014·0 cites·19 claims
- 1534US2012058183A1Retigabine tablets, preferably having modified releaseBRUECK SANDRA·Filed 2010·Application pending·0 cites
- 1631US9085507B2Desfesoterodine in the form of a tartaric acid saltFISCHER DIRK·Filed 2010·Granted Jul 21, 2015·0 cites·15 claims
- 1731US2013095177A1Method of preparing an oral dosage form comprising fingolimodPAETZ JANA·Filed 2011·Application pending·0 cites
- 1829US2012258171A1Composition comprising fesoterodine and fiberSTUMM DANIELA·Filed 2010·Application pending·0 cites
- 1929US2012053238A1Solid retigabine in non-crystalline formPAETZ JANA·Filed 2010·Application pending·0 cites
- 2026US2012202820A1Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptinRIMKUS KATRIN·Filed 2010·Application pending·0 cites
- 2124US2012189694A1Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereofRIMKUS KATRIN·Filed 2010·Application pending·0 cites
- 2222US2012122973A1Dry processing of retigabinePAETZ JANA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →